Edwards Lifesciences Corp

مادة اعلانية

Latest Update: 27 Feb 2026 20:13 Abu Dhabi Time.

Market Status: Opened

86.54

USD

0.640

0.75%

Open

85.35

Prev Close

85.90

PX_VOLUME

MARKET CAP (M)

DAY RANGE

85.52 - 86.80

52 WEEKS

65.94 - 87.89

Stock Statistics

Yearly Change

19.37%

Listed Shares (Million)

658.70

Earnings Multiple

46.87

Average 30-day trading volume

4,268,971.03

Price-to-book ratio

4.83

Earnings Per Share

1.81

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		1,569.60	1,553.10	1,532.20	1,412.70	1,385.80	1,354.40	1,369.40	1,329.90	1,266.40	1,243.40
Gross Profit		1,226.60	1,207.90	1,187.80	1,111.10	1,093.60	1,091.50	1,093.90	1,043.00	1,015.40	992.80
Operating Income		370.30	425.10	430.90	409.90	353.30	394.30	374.60	357.90	356.70	368.10
Net Income		64.20	292.30	335.90	363.60	345.00	362.10	364.00	324.90	333.10	334.90
Profit Margin		4.09	18.82	21.92	25.74	24.90	26.74	26.58	24.43	26.30	26.93

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		6,067.60	5,439.50	5,010.00	4,464.00	5,232.50	4,386.30
Gross Profit		4,733.40	4,322.00	4,031.60	3,740.30	3,983.60	3,305.70
Operating Income		1,636.20	1,480.10	1,486.20	1,539.10	1,586.80	1,316.60
Net Income		1,056.00	1,396.00	1,220.00	1,324.00	1,503.10	823.40
Profit Margin		17.40	25.66	24.35	29.66	28.73	18.77

Balance Sheet

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		13,272.20	13,488.70	13,022.30	13,055.30	12,971.20	10,099.30	9,736.30	9,363.20	9,370.80
Total Liabilities		3,067.20	2,882.20	2,830.70	2,992.40	3,359.80	2,594.70	2,549.90	2,643.80	2,643.70
Total Equity		10,205.00	10,606.50	10,191.60	10,062.90	9,611.40	7,504.60	7,186.40	6,719.40	6,727.10

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		13,055.30	9,363.20	8,292.50	8,502.60	7,237.10
Total Liabilities		2,992.40	2,643.80	2,485.80	2,666.70	2,662.80
Total Equity		10,062.90	6,719.40	5,806.70	5,835.90	4,574.30

Cash Flows Statements

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		573.70	290.20	280.40	-127.50	351.80	371.50	-53.50	136.60	411.50
Cash From Investing Activities		-427.80	-172.10	85.30	-576.70	2,701.70	124.80	63.10	14.10	89.00
Cash From Financing Activities		-740.10	52.70	-258.00	28.60	-976.70	-96.60	61.70	-413.20	-143.30
Net Change in Cash		-595.20	141.20	90.00	-624.60	2,025.30	429.10	81.00	-265.90	366.40

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		542.30	895.80	1,218.20	1,732.10	1,054.30
Cash From Investing Activities		2,312.90	173.80	252.30	-1,722.50	-531.10
Cash From Financing Activities		-983.00	-711.00	-1,584.50	-356.30	-486.90
Net Change in Cash		1,910.80	375.40	-94.80	-332.80	15.80

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

Edwards Lifesciences Corp

إدواردز لايفسيانسز كورب